and specifically for the diagnosis of an autoimmune pathology like the celiac disease, where the enzyme was suggested to be the major autoantigen [22] . In the last decade Streptoverticillium mobaraense isoform, a TGase of microbial origin possessing wide substrate specificity, calcium independence and high thermostability, has been largely utilized as a biotechnological tool, but mostly in the food field [23, 24] .
In this chapter we describe the main applications of the multiple TGase molecular isoforms in different sectors, from biomedicine to cosmetics, from food to leather and textile industries.
Biomedicine
The applications of TGase in biomedicine are directly related to the studies on the physiological role of each enzyme isoform, on the identification of new endogenous and exogenous substrates, and on the enzyme capability to modify the biological properties of the proteins able to act as acyl donor and/or acceptor substrates.
Investigations on the physiological role of Factor XIII have allowed to design products for therapeutic use of this isoenzyme. As it is well known, coagulation Factor XIII (fibrin stabilizing factor) is a TGase that circulates in blood plasma as an inactive heterotetramer consisting of two catalytic A and two regulatory B subunits (A 2 B 2 ), both of which are synthesized and secreted by the liver. Factor XIII is converted into the fully active enzyme (Factor XIIIa) by a thrombin-mediated proteolysis occuring in the final stage of the blood coagulation cascade. Once produced, Factor XIIIa cross-links fibrin aggregates both stabilizing them against mechanical stress and proteolytic degradation and incorporating proteinase inhibitors into the fibrin clot. Factor XIIIa activity suggested the design of products with blood clotting properties to be used for bleeding control during surgery. Thus, the aim to produce fibrin sealants was reached by different enterprises promoting new therapeutic preparations, like Tissucol kit (by Baxter) and Tisseel kit (by Immuno), both containing Factor XIII and used for the treatment of postsurgery hemostatis. Also the 'tissue' TGase has been proposed as biological glue because of its capability to cross-link proteins occurring in the extracellular matrix. Its use in promoting cell adhesion for the coating of medical implants has been, in fact, recently patented [25] .
Other commercial products related to Factor XIII involve its administration in patients affected by Factor XIII deficiency, a very rare bleeding disorder either inherited or acquired [26] which is characterized by the production of defective and unstable blood clots in response to tissue damage. Replacement therapy in Factor XIII deficiency has been proved to be generally straightforward owing to the low levels of Factor XIII required to control bleeding. Nowadays two commercial products are available for substitutive therapy with plasma-derived Factor XIII (Factor XIII from Bio Products Laboratory and Fibrogammin P from Centeon).
Further application of TGase in biomedicine is related to the therapeutic treatment of the 'excessive or hypertrophic scarring', a pathological state characterized by the occurrence of hypertrophic scars following a dermal insult, such as surgery, grafting, trauma and severe burns. Hypertrophic scars are characterized by being thick, red, painful and itchy and can cause functional deficits when they occur across a joint. In the wound healing process 'tissue' TGase plays a role in the production of -(␥-glutamyl)lysine cross-links with the formation of insoluble collagen matrices. In hypertrophic scarring 'tissue' TGase is found to be overexpressed resulting in both an overhealing process and an excess of collagen deposition. After assessing the effectiveness of polyamines as alternative acyl acceptor substrates of 'tissue' TGase [27] , Procyon Biopharma Incorporation developed Fibrostat ® , a topical cream containing putrescine. The development status of Fibrostat ® is currently in phase IIb of clinical trial to further evaluate the safety and the effectiveness of the product [28] .
Moreover, the progress in the knowledge of the etiology of the celiac disease has pointed out the importance of 'tissue' TGase as an effective diagnostic tool. In fact, the identification of 'tissue' TGase as the major autoantigen of celiac disease, against which the endomysial antibody is directed [22] , led to more extensive understanding of the pathogenesis of this immunologically mediated intolerance to wheat gliadins. These findings also allowed to change the technique by which the diagnosis of the disease was made. In fact, previous methods based on the identification of antiendomysium antibodies have been replaced by the immunological detection through ELISA tests of IgA autoantibodies against 'tissue' TGase. First generation tests, identifying IgA class anti-'tissue' TGase antibodies, used the enzyme purified from guinea pig liver as antigen [29] [30] [31] . However, since several studies demonstrated significant differences in the performance of the guinea pig enzyme compared to the human isoform, human TGase antigen-based kits have been recently developed. Most of them contain a recombinant form of the enzyme, expressed either in E. coli or in Baculovirus/insect cell systems, together with antibodies raised against both types of the recombinant forms.
Another pathology related to a member of the TGase family is the lamellar ichthyosis, a disfiguring skin disease characterized by an abnormal epidermal differentiation and a reduced cutaneous barrier function. Since it has been established that lamellar ichthyosis patients possess a defective keratinocyte TGase (type 1) gene [9] , several studies have been carried out in the attempt to design gene therapy-based medical approaches to restore TGase 1 activity.
Both retroviral and plasmid vectors have been used for delivering engineered molecules and two different procedures have been investigated to optimize cutaneous gene delivery. The first one involves grafting of primary keratinocytes derived from lamellar ichthyosis affected patients and cell transformation with normal TGase 1 [32] . The second, representing a less labor intensive approach, consists in the direct injection of the vector harboring normal TGase 1, as naked DNA, into intact skin [33] . The unsatisfactory results obtained with both systems indicate that further studies are needed to apply gene therapy to this kind of disease.
A role played by TGase in some neurodegenerative disorders, such as Alzheimer's, Huntington's and Parkinson's diseases, has been also suggested [34] . The involvement of the enzyme has been hypothesized since some proteins related to these pathologies have been proven to act as TGase substrates and an increase in TGase activity was observed. For example, 'huntingtin', the protein product of the mutated gene responsible for Huntington's disease, is known to be characterized by the presence of polyglutamine stretches in its aminoacid sequence. In vitro studies demonstrated that this protein is able to act as substrate of 'tissue' TGase and that an elevated enzyme activity occurs in the affected cerebral regions [35] . It has been demonstrated that administration of the TGase inhibitor cystamine caused an improvement in patient survival as well as in the symptoms associated with neurodegeneration [36] .
Cosmetics
Applications in this field are, in general, related to TGase ability to covalently bind specific compounds containing primary amino groups to keratinocyte proteins known to act as acyl donor substrates. Thus, a method to deliver a large variety of compounds (i.e. sunscreens, antimicrobials, either skin or hair conditioning agents, anti-inflammatory and antioxidants drugs, colorants, perfumes, insect repellents) has been patented [37] . Moreover, topical preparations containing TGase and one or more proteins occurring in the stratum corneum of the skin (like involucrin, loricrin, cornifin) have also been described. The effect of these products is related to the formation of a protective film useful for the care of hair, skin and nails [38] . Another topical preparation, containing an inhibitor of TGase and possessing the property to alter the rate of mammalian hair growth, has been patented. This kind of product could be of interest to remove undesired hair in specific parts of the human body [39] . Finally, microparticles containing TGase-substrate reactive groups, which can be cross-linked to the skin surface by either endogenous or exogenous TGase, represent an additional pharmaceutical proposal [40] . However, even though to our knowledge the products related to the aforementioned patents are not at the moment on the market, it is predictable that a large number of skin care preparations derived from investigations in this field will be available soon.
Food
Most preliminary studies addressed to the TGase-catalyzed modifications of proteins of food interest have been carried out with the enzyme purified from guinea pig liver or bovine plasma. The limited supply of these isoforms and the high costs of their production inhibited the development of technologies involving TGase in food processing to enhance texture and emulsion properties of protein-based foods.
In 1989 a microbial TGase was isolated from Streptoverticillium sp. and its characterization indicated that this isoform could be extremely useful as a biotechnological tool in food industry [41] . In fact, microbial TGase was shown to be active over a wide range of temperatures and stable between pH 5 and 9, as well as to possess a calcium-independent activity [42] . This isoform has been 'Generally Recognized As Safe' and its use is allowed as food additive. Ajinomoto Incorporation actually produces several preparations of microbial TGase that are commercialized with different names. They differ in stabilizer composition in relation to the type of food for the production of which they have been designed. For example, Activa WM, a powder which contains 1% TGase and 99% maltodextrins, was described to enhance the texturizing properties of meat-based foods and successfully used to prepare novel dairy products [43] . Conversely, Activa MP, which contains lactose besides maltodextrins as stabilizer, was suggested to be used in modifying milk protein-based foods as cheese or yogurt. To date, even though many typical oriental foods are already produced in the presence of TGase as adjuvant, the use of the enzyme is certainly destined to be spread out worldwide in the future. In agreement with the European legislation (Directive 89/107/EC), Ajinomoto declared that TGase could be considered as a processing aid and, thus, its presence does not need to be indicated in the finished products.
Seafood Products
The use of TGase in food industry started in Japan to prepare surimiderived products (fish paste). One of this, kamaboko, is thought to date as far back as 1,100. To become surimi, fish is skinned, boned, repeatedly rinsed to eliminate any fishiness and pigments and ground into a paste. This odorless white paste is then mixed with a flavor concentrate made from real shellfish.
The paste is then formed, cooked and cut into the desired shapes. Since the presence of endogenous TGase has been detected in species of pollack, fish used for surimi [44] , several experiments have been carried out to assess the effect of TGase on the physical properties of surimi gels [45] [46] [47] [48] . There are no doubts that both endogenous fish TGase and exogenous microbial TGase are able to improve the texture of the raw materials by catalyzing the formation of -(␥-glutamyl)lysine cross-links between fish proteins. In particular, the addition of exogenous microbial TGase is certainly responsible for increasing elasticity and firmness of the surimi gel.
Meat Products
Also the use of TGase to prepare meat products is based on studies showing that several meat-related proteins are able to act as substrates of the enzyme. In fact, Factor XIIIa-catalyzed cross-link formation between fibrin and fibronectin, fibrin and actin, myosin and fibronectin, and myosin and actin was previously demonstrated [49] . Further studies reported the capability also of guinea pig 'tissue' TGase to modify meat proteins [10] . Finally, most recent investigations demonstrated the effectiveness of the microbial isoforms of the enzyme to produce different types of meat-based foods by using successfully beef, poultry and pork to prepare restructured products. For example, it has been described that the texture of chicken sausages, which originally showed a gel strength weaker in comparison with the pork sausages, was significantly improved by TGase. Thus, the enzyme offers the possibility of creating new poultry products with improved textural characteristics.
The most significant advantage in the utilization of the enzyme in meat processing is due to the ability of TGase to efficiently substitute salts and phosphates, generally used in the traditional procedures of meat binding and texturing. In the alternative process involving TGase, a mixture of the enzyme and sodium caseinate, added to the meat pieces, allows the formation of cross-links among the casein molecules and the resultant meat product can then be cooked without breaking apart [50] . Nowadays, this process is extensively used to restructure meat from many different sources and to produce corresponding food products that visually and texturally meet consumer demands.
Dairy Products
Modifications of milk proteins by TGase have been extensively studied. The ability of milk proteins to act as TGase substrates was preliminary investigated by using both the enzyme purified from guinea pig liver and the blood coagulation Factor XIII, while more recent studies involved the utilization of the microbial isoform of the enzyme. Experiments carried out using single milk proteins allowed to establish that caseins are effective substrates for TGase, even if ␣s1-, ␤-and -casein react differently with the enzyme depending on the isoform used. In fact, Ikura et al. [51] reported a lower reactivity of -casein, compared to ␣s1-and ␤-caseins, with the guinea pig liver enzyme, whereas ␣-casein was shown to act less effectively as acyl donor substrate for the blood coagulation enzyme in comparison with both ␤-and -caseins [52] . More recently, Cozzolino et al. [43] demonstrated no significant differences among the different caseins by using microbial TGase, the preferred isoform both to produce new protein ingredients and to change the texture of food products.
Most studies have also demonstrated the effectiveness of TGase to prepare novel yogurts. Kuraishi et al. [24] reported that a yogurt made in the presence of TGase possesses improved gel strength and viscosity as a consequence of its enhanced water-holding properties. Moreover, microbial TGase has been recently proposed for producing whey protein-enriched cheeses by adding the enzyme during the manufacturing process [43] . The obtained new products showed an increased hardness and deformability, depending on the amount of the enzyme used, as well as increased protein content. Development of this kind of dairy production is desirable since it would represent a way for the re-utilization of dairy plant by-products, thus contributing to decrease the environmental pollution due to the whey protein disposal.
Soy Products
Soy proteins are of great interest in the world food industry since they are widely used as ingredients in a variety of western products, such as sausages and ham, as well as being the basic component of typical eastern foods. Their importance is related to their ability to undergo gelation after thermal treatment. It is well known that gelled proteins provide some useful textural properties to different foods. It has been extensively studied how TGase-mediated polymerization of both soy 7S and 11S globulins influences soy protein gel properties. Chanyongvorakul et al. [53] and Kang et al. [54] reported that TGase-induced 11S globulins gels are more rigid and elastic than the corresponding thermally induced gels. The authors proposed that rigidity might be due to an extensive cross-linkage, since it was possible to influence the protein textural quality by varying enzyme concentration. These molecular studies suggested the utilization of TGase in the manufacturing of tofu, the major soy product in Asia. The use of TGase, together with magnesium chloride acting as coagulant, provides a tofu with a smoother, firmer texture. These new properties depend on an enhanced breaking strength compared to that of tofu obtained in the absence of the enzyme. Tofu prepared with TGase also exhibits an increased water-holding capacity, probably because of the presence of more stable covalent cross-links that hold more water despite the temperature changes.
Cereal-Based Products
Wheat is known as one of the most important cereals for human nutrition and many reports indicate that wheat proteins are able to act as TGase substrates. Porta et al. [55] demonstrated the reactivity of different cereal proteins as acyl donor substrates for 'tissue' TGase and that wheat globulins, glutenins and gliadins were more effective than prolamins from oat, maize and rice. Different authors reported similar results by using the microbial isoform [56] . The rheological properties of gluten modified following the formation of -(␥-glutamyl)lysine cross-links were also investigated. Viscoelasticity of TGase-treated gluten, as well as its sensitivity to thermal processing, was reduced compared to that of the unmodified gluten. Therefore, the enzymatic treatment was shown to cause a considerable reinforcement of the network. These studies have promoted the use of TGase to prepare noodles and pasta in Japan. TGase, added when flour and other ingredients are mixed, confers to both pasta and noodles a firmness higher than that of untreated products, indicating that this characteristic depends on the enzyme amount [24] . In addition, since the cross-links introduced by TGase are heat stable, firmness and elasticity of noodles and pasta are retained even after cooking.
The use of the enzyme showed beneficial effects also on breadmaking. In fact, TGase improves dough elasticity and its utility in breadmaking is similar to that of the oxidizing improvers [57] .
Finally, recent studies investigated the possibility to modify rice flour proteins with the aim to use this important cereal for breadmaking. In its natural conditions rice flour is used only to make unfermented baked products since rice proteins are unable to hold gas produced during fermentation. Conversely, Gujral and Rosell [58] have demonstrated that TGase-modified rice proteins provide a protein network effective in holding gas produced during fermentation.
Edible Films
An increasing interest toward edible films has been registered in the last few years mostly for their potential use in food industry. First of all, edible films can represent an alternative to the chemically synthesized polymeric films that are, nowadays, widely used for packaging. Since latter films are not environment friendly, development of films constituted by edible and biodegradable components is strongly advisable. Moreover, edible films have substantial possibilities to enhance stability and quality of foods. Their functional efficiency strongly depends on the nature of the components that can be, typically, hydrocolloids and/or lipids. Many scientific papers and patents refer to films constituted by different proteins, like collagen, casein, wheat gluten and whey and soy proteins, whereas most of the effects of TGase treatment on film properties have been studied using the guinea pig purified enzyme. Utilization of whey proteins for the production of packaging films was investigated by Mahmoud and Savello [59, 60] . Additional studies were carried out using ␣s1-casein [61] , 11S globulin [62] and egg white proteins [63] . Cross-links introduced by TGase confer on films a precise network that influences mechanical and permeability properties, reflecting characteristics at microstructural level. Smoother surface and higher homogeneity are features found in microbial TGase-synthesized film made with whole soy flour and pectin [64] . Such films exhibit also an increased strength, are less flexible, and less permeable to oxygen, carbon dioxide and water vapour [65] . It is worthy to note that TGase-mediated polymerization modifies, among the proteins occurring in soy flour, the soybean vacuolar protein, known to possess allergenic properties and that can be neutralized also by the Maillard reaction [66] .
Finally, edible films have also been proposed as vehicles to carry substances to monitor and/or to influence the quality of wrapped foods. In this way, edible films may represent an active packaging and its use might be extended outside the food sector if the vehiculated substances are specific drugs [10] .
Nutritional Aspects of TGase-cross-linked Proteins
The evaluation that so many applications of TGase exist in food processing raises questions about the nutritional value of the proteins containing isopeptide bonds. In this respect bioavailability and digestibility of the glutamine-lysine cross-links deserve to be considered. It has been established that a number of isopeptide bonds occur in many tissues of different animals that are commonly eaten. One explanation of this phenomenon is related to the presence of different endogenous TGase isoforms responsible for the cross-links formation in uncooked foods. But also the processed foods, including the Japanese kamaboko, ham, fried chicken, grilled pork, and hamburger, were found to contain ␥-glutamine--lysine isopeptide bonds. In particular, cooked foods have an higher content of isopeptide bonds compared to raw food, probably because at the beginning of the process endogenous TGases become more active and are able to better catalyze the formation of cross-links.
On the other hand, enzymes able to hydrolyze the ␥-glutamine--lysine dipeptide, which is not susceptible to gastrointestinal proteolysis, have been described. In particular, kidney was shown to be provided with the enzyme ␥-glutamylamine cyclotransferase [67] , while a different ␥-glutamyl transferase was demonstrated to be present mainly in intestinal brush-border membranes and blood [68] . Lysine, which is an essential amino acid, is generated from the cleavage operated by these two enzymes and is readily available and nutritionally beneficial. As a matter of fact, Seguro et al. [69] demonstrated that rats fed with TGase-cross-linked caseins grew as much as control rats fed with unmodified caseins.
Leather and Textile Industries
The use of TGase also is of interest for other industrial sectors. In the leather industry casein is used to coat leather through a process that involves hardening agents such as aldehydes, isocyanates or aziridine. Because of the high toxicity of these agents, for both operators and environment, new and different methods are demanded. In this respect the application of TGase-modified casein as a coating has been patented [70] and its wider use in leather manufacturing is to be desired.
More recently, studies have been carried out demonstrating the importance of TGase also for the wool finishing industry [71] . To overcome both felting and shrinkage problems of wool fibers, chemical processes are currently used. Most of them involve acid chlorination of the wool goods or the application of permonosulphuric acid. Although these methods concur to confer a significant level of shrink-resistance to the wool, they are of high environmental impact due to the toxicity of the reagents used. On the other hand, the alternative technique based on the use of proteases to prevent shrinkage, a problem occurring after repeated laundering, results in an undesired reduction of wool fibre strength and weight. Cortez et al. [72] have demonstrated, by using both guinea pig liver and microbial TGases, that the enzyme increases tensile strength of the wool products, in some cases completely reverting the loss caused by a previous proteolytic treatment. Protease pre-treatment enhances the effect of subsequent TGase treatment since it causes an increase in accessibility of the fibres to protein cross-linking. Finally, even in the absence of exogenous TGase addition, fibre matrix is stabilized, beside the most abundant disulphide bonds, also by (␥-glutamyl)lysine bonds catalyzed mainly by keratinocyte and epidermal TGases that normally confer resistance to hair and wool.
Cortez et al. [72] have also demonstrated that both TGase isoforms may be used to incorporate the primary amine substrate fluorescein cadaverine into wool fibres. This result suggests a possible use of the enzyme also to incorporate functional agents as antimicrobials, water repellents and perfumes, as far as they are provided with an alkylamino side group [72] . It is worthy to note that these studies have underlined the different substrate specificities of microbial and tissue TGases towards wool proteins. In fact, microbial enzyme was used at a protein concentration 20 times higher than that of guinea pig liver TGase. Only the availability of recombinant 'tissue' TGase obtained at low costs, hence competitive with the microbial isoform, will allow its wider use as a biotechnological tool, becoming more popular in this field of interest.
Analytical Biotechnology Applications
Avidin-biotin technology attracts a great interest because of its ability to replace many tests employing radioactively labeled materials. Thus, this system is frequently utilized to identify proteins which have been biotinylated. It has been demonstrated that both acyl acceptor and donor TGase substrates are still able to be modified by the enzyme after they have been previously biotinylated. Often the biotinylated molecules are useful to demonstrate whether a peptide or a protein is a TGase substrate. Josten et al. [73] have used biotinylated compounds endowed with an acyl acceptor amino group to obtain biotinylated antibodies. In particular, by using microbial TGase for the biotinylation of a monoclonal IgG against the herbicide 2,4-dichlorophenoxyacetic acid, they demonstrated that the biotinylated antibody exhibited the appropriate biological activity.
TGase has also been proposed to synthesize products useful for immunochemical assays. Testing of antibodies against small molecules, such as haptens, is routinely performed by ELISA techniques. For accurate results, it is essential to provide an efficient coupling of the hapten to a protein carrier in order to obtain conjugates to be used to coat the microplates in which immunoassays are carried out. As long as hapten is provided with an acyl acceptor group, it can be incorporated through TGase into an acyl donor substrate. Josten et al. [74] have demonstrated the effectiveness of microbial TGase to cross-link an aminofunctionalized hapten to casein, a typical acyl donor substrate for the enzyme, which is currently used to coat plates for immunoassays. Similar results were obtained by other authors by using 'tissue' TGase [61] . Enzymatic synthesis of the conjugates is advisable since chemical procedures are time and labor consuming and the degree of conjugation is hard to achieve. Conversely, enzymatic catalysis is highly reproducible and needs reduced times for conjugation.
The use of microbial TGase for the development of biosensors has also been successfully exploited. In particular, the microbial enzyme was used to prepare a protein matrix, constituted by TGase-cross-linked casein or fibrinogen, onto which model enzymes like glucose oxidase or lactate oxidase were entrapped [75] .
It was demonstrated that lactate enzyme sensors, obtained by microbial TGase-mediated immobilization, exhibited a higher storage and operational stability compared to sensors prepared by chemical cross-linking through glutaraldehyde. In contrast to other enzyme membranes, prepared by entrapment of enzymes in hydrogels, the TGase-mediated network remains homogeneous during drying in air with beneficial effects on the reproducibility of the enzyme sensors.
Other Applications
TGase was recently also proposed as a tool to synthesize glycosylated proteins to be employed in different sectors, from food industry to medical field. Thus, microbial TGase has proved to be effective to prepare trypsinoligosaccharide conjugates with improved stability properties of the proteolytic enzyme. Trypsin, widely used in food manufacturing and processing industry, is able to act as acyl donor for TGase and to incorporate different types of aminoderived cyclodextrins, compounds previously employed as physical additives to increase the solubility and the catalytic properties of various enzymes in organic media. In particular, TGase-synthesized trypsin-cyclodextrin conjugates have been shown to exhibit significantly improved both specific esterolytic activity and kinetic constants, besides being more resistant to autolytic degradation at alkaline pH and to heat inactivation [76, 77] .
The effectiveness of glycosylation through TGase in the medical field was exploited to modulate the biological properties of interleukin-2, a lymphokine with important immunoregulatory functions [78] . In particular, polyethyleneglycol modified with an alkylamine straight chain was used as acyl acceptor substrate. Interleukin-2, acting as glutamine donor substrate, showed an improved capability to survive in the blood circulation of treated rats after TGase modification. In fact, unmodified interleukin-2 showed an half life of only 5.5 min, while TGase glycosylated lymphokine exhibited an half life almost 40 times higher [78] .
Conclusions
In this chapter we describe a quite wide panorama on the most revelant biotechnological applications of TGases. The potentiality offered by this class of enzymes in creating many different products is shown in figure 1 . Due to their capacity of synthesizing isopeptide bonds, homo-and heteropolymers may be formed with the consequence of obtaining products with new or improved features. Biological activities of proteins and peptides can be also influenced by incorporating polyamines and/or aminosugars. In addition, a different performance can be induced in a protein by its partial TGase-catalyzed deamidation converting one or more glutamine residues in glutamic acid(s). Finally, the use of the enzyme has been successfully exploited in analytical biotechnology with the aim both to synthesize effective biotinylated antibodies and to immobilize enzymes acting as biosensors. In many of these applications, the use of TGase resulted alternative to chemical modification methods that often give rise to toxicity problems for users and provoke environmental pollution.
In conclusion, the reported studies indicate that TGase-based methodologies are destined to have further important applications in many different industrial sectors. Thus, the development of novel inexpensive sources of the enzyme represents a crucial point for future research studies. To date, the most convenient TGase as a biotechnological tool is the enzyme purified from Streptoverticillium mobaraense, even though this isoform seems to be useful mainly in the food sector. For different applications, the production in large amounts of other isoforms, i.e. Factor XIII or 'tissue' TGase, is needed. One promising approach to obtain these enzymes at low costs involves the genetic manipulation using heterologous hosts. By this way, the expression of recombinant human Factor XIII was obtained using both E. coli [79, 80] and yeast [81] systems as bioreactors. In the same manner, the recombinant 'tissue' TGase has been produced in E. coli [82, 83] and Baculovirus/insect cells [84] and used as reliable antigen for the diagnosis of celiac disease. However, the high costs of production suggest to find alternative systems. More recently, plants have been proposed as effective hosts for the biosynthesis of mammalian proteins [85] . Gao et al. [86] engineered tobacco plants producing Factor XIIIa with the aim to obtain a recombinant isoform which could replace Factor XIII occurring in the commercially available therapeutic products. Similarly, Nicotiana tabacum-derived cells have been recently investigated as bioreactor for the production of human 'tissue' TGase. A catalytically active form has been efficiently produced and the partially purified enzyme shown to be effective in recognizing anti-TGase antibodies present in celiac patient antisera [87] . Thus, the perspective that new transgenic sources may provide large amounts of the different TGase isoforms useful for various biotechnological applications should be considered at the moment more than a simple possibility.
